ABI1 and colorectal carcinoma: In summary, we believe that ABI1-TSV-11 is a specific prognostic factor and therapy target for LsCC, and the current results of this study open up a new field for us to use TSV-specific nucleic acid detection technology61 and ASO (antisense oligonucleotide) target technology62 for the diagnostic classification, prognostic evaluation, and targeted treatment of CRC metastasis.